Morgan R - Search Results

1

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.

Heinemann L, Simpson GR, Boxall A, Kottke T, Relph KL, Vile R, Melcher A, Prestwich R, Harrington KJ, Morgan R, Pandha HS. Heinemann L, et al. Among authors: morgan r. BMC Cancer. 2011 Jun 6;11:221. doi: 10.1186/1471-2407-11-221. BMC Cancer. 2011. PMID: 21645351 Free PMC article.

2

Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model.

Ismail M, Morgan R, Harrington K, Davies J, Pandha H. Ismail M, et al. Among authors: morgan r. Cryobiology. 2009 Oct;59(2):207-13. doi: 10.1016/j.cryobiol.2009.07.008. Epub 2009 Jul 29. Cryobiology. 2009. PMID: 19646431

3

Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma.

Pandha HS, Heinemann L, Simpson GR, Melcher A, Prestwich R, Errington F, Coffey M, Harrington KJ, Morgan R. Pandha HS, et al. Among authors: morgan r. Clin Cancer Res. 2009 Oct 1;15(19):6158-66. doi: 10.1158/1078-0432.CCR-09-0796. Epub 2009 Sep 22. Clin Cancer Res. 2009. PMID: 19773377 Free article.

4

Targeting HOX and PBX transcription factors in ovarian cancer.

Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS. Morgan R, et al. BMC Cancer. 2010 Mar 10;10:89. doi: 10.1186/1471-2407-10-89. BMC Cancer. 2010. PMID: 20219106 Free PMC article.

5

Differential effects of Paclitaxel on dendritic cell function.

John J, Ismail M, Riley C, Askham J, Morgan R, Melcher A, Pandha H. John J, et al. Among authors: morgan r. BMC Immunol. 2010 Mar 19;11:14. doi: 10.1186/1471-2172-11-14. BMC Immunol. 2010. PMID: 20302610 Free PMC article.

6

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.

Twigger K, Roulstone V, Kyula J, Karapanagiotou EM, Syrigos KN, Morgan R, White C, Bhide S, Nuovo G, Coffey M, Thompson B, Jebar A, Errington F, Melcher AA, Vile RG, Pandha HS, Harrington KJ. Twigger K, et al. Among authors: morgan r. BMC Cancer. 2012 Aug 24;12:368. doi: 10.1186/1471-2407-12-368. BMC Cancer. 2012. PMID: 22920673 Free PMC article.

7

Targeting HOX transcription factors in prostate cancer.

Morgan R, Boxall A, Harrington KJ, Simpson GR, Michael A, Pandha HS. Morgan R, et al. BMC Urol. 2014 Feb 5;14:17. doi: 10.1186/1471-2490-14-17. BMC Urol. 2014. PMID: 24499138 Free PMC article.

8

HOX transcription factors are potential targets and markers in malignant mesothelioma.

Morgan R, Simpson G, Gray S, Gillett C, Tabi Z, Spicer J, Harrington KJ, Pandha HS. Morgan R, et al. BMC Cancer. 2016 Feb 11;16:85. doi: 10.1186/s12885-016-2106-7. BMC Cancer. 2016. PMID: 26867567 Free PMC article.

9

Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma.

Morgan R, Pirard PM, Shears L, Sohal J, Pettengell R, Pandha HS. Morgan R, et al. Cancer Res. 2007 Jun 15;67(12):5806-13. doi: 10.1158/0008-5472.CAN-06-4231. Cancer Res. 2007. PMID: 17575148

10

Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P.

Shears L, Plowright L, Harrington K, Pandha HS, Morgan R. Shears L, et al. Among authors: morgan r. J Urol. 2008 Nov;180(5):2196-201. doi: 10.1016/j.juro.2008.07.018. Epub 2008 Sep 20. J Urol. 2008. PMID: 18804814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,813 results

Search Page